Selinexor inhibits growth of patient derived chordomas in vivo as a single agent and in combination with abemaciclib through diverse mechanisms

MLA

Christopher J. Walker, et al. “Selinexor Inhibits Growth of Patient Derived Chordomas in Vivo as a Single Agent and in Combination with Abemaciclib through Diverse Mechanisms.” Frontiers in Oncology, vol. 12, Aug. 2022. EBSCOhost, https://doi.org/10.3389/fonc.2022.808021.

APA

Christopher J. Walker, Hua Chang, Leah Henegar, Trinayan Kashyap, Sharon Shacham, Josh Sommer, Michael J. Wick, Joan Levy, & Yosef Landesman. (2022). Selinexor inhibits growth of patient derived chordomas in vivo as a single agent and in combination with abemaciclib through diverse mechanisms. Frontiers in Oncology, 12. https://doi.org/10.3389/fonc.2022.808021

Chicago

Christopher J. Walker, Hua Chang, Leah Henegar, Trinayan Kashyap, Sharon Shacham, Josh Sommer, Michael J. Wick, Joan Levy, and Yosef Landesman. 2022. “Selinexor Inhibits Growth of Patient Derived Chordomas in Vivo as a Single Agent and in Combination with Abemaciclib through Diverse Mechanisms.” Frontiers in Oncology 12 (August). doi:10.3389/fonc.2022.808021.